SAN DIEGO--(BUSINESS WIRE)--Stemedica Cell Technologies (“Stemedica”) announced today the addition of Paul A. Frohna, MD, PhD, PharmD, to the company’s management team as Vice President, Clinical Research and Regulatory Affairs. Paul joins Stemedica from FibroGen, Inc., where he has been serving as Acting Vice President for Clinical Development.
